Today

Agents

Chat

Arena

Discover

More

App

Taysha Gene Therapies Q2 Net Income USD -46.639 Million - TSHA News | Rallies

Taysha Gene Therapies Q2 Net Income USD -46.639 Million

TSHA•2026-08-11

Q2 results

Aug. 11 (Reuters) - Taysha Gene Therapies Q2 operating expenses were USD 47.349 million.

Q2 operating income was USD -47.349 million.

Related News

Barrel Energy meraih pembiayaan pinjaman USD 150.000 dari Coventry Enterprises

BRLL•2026-08-11

Aura Biosciences May Offer Securities Up To $500 Million Aggregate

AURA•2026-08-11

Marriott International Prices $250.0M 4.875% Series NN Notes Due 2029 And $1,000.0M 5.650% Series YY Notes Due 2036

MAR

•

2026-08-11

Megan Holdings umumkan rapat umum luar biasa pemegang saham

MGN•2026-08-11

HIVE Digital menunda laporan keuangan kuartalan karena evaluasi akuntansi sengketa PPN di Swedia

HIVE•2026-08-11